Todd Harris

Title: The Innovations of Todd Harris: A Pioneer in Dual Inhibitor Development

Introduction

Todd Harris, an innovative inventor based in Davis, California, has made significant strides in the field of pharmacology. With one patent to his name, he has contributed to the development of new biopharmaceuticals that could revolutionize treatment options for various health conditions. His work showcases the intersection of creativity and science, pushing the boundaries of what is possible in medical treatments.

Latest Patents

Todd Harris holds a notable patent for "Orally available sEH/PDE4 dual inhibitors." This patent presents novel bioavailable dual inhibitors that are capable of inhibiting both soluble epoxide hydrolase (sEH) and phosphodiesterase 4 (PDE4). The methods provided in the patent outline potential uses for these inhibitors, highlighting their promise in enhancing therapeutic outcomes.

Career Highlights

Throughout his career, Todd has been affiliated with prestigious institutions such as the University of California and Goethe University Frankfurt. These environments have allowed him to advance his research and work collaboratively with leading scientists in the field.

Collaborations

In his journey, Todd Harris has collaborated with notable colleagues, including Bruce D. Hammock and Rene Bloecher. These partnerships have been instrumental in fostering innovative research and have significantly contributed to the success of his patented inventions.

Conclusion

Todd Harris exemplifies the spirit of innovation and collaboration in the realm of biomedical research. His development of orally available sEH/PDE4 dual inhibitors reflects a significant advancement in therapeutic possibilities, showcasing how dedicated inventors can impact the future of medicine. As the fields of pharmacology and biotechnology continue to evolve, Todd Harris remains a key figure to watch in the world of inventions and innovation.